Clinical Trials Browser

Phase 1 × Breast Neoplasms × LY3295668 erbumine × Clear all

NCT03955939 2020-06-01

A Study of LY3295668 Erbumine in Participants With Breast Cancer That Has Spread to Other Parts of the Body

Phase 1 Completed

Breast Neoplasms, Epilepsy